Genomics England
Illumina, Genomics England Ink Deal to Sequence up to 300K People
The deal provides whole-genome sequencing for patients with rare diseases or cancer and could make sequencing part of the standard of care for NHS England.
UK's NHS Prepares Transition to Diagnostic Genome Sequencing for Rare Diseases, Some Cancers
Premium
Diagnostic WGS will be centralized and performed at the same Genomics England facility used in the 100,000 Genomes Project.
As 100K Genomes Project Returns Patient Reports, NHS Prepares to Commission WGS for Diagnostics
Premium
As of this week, the project had sequenced 39,500 genomes and returned reports for about 3,000 rare disease families and more than 600 cancer patients.
Congenica will use the proceeds to establish its presence in the US and China, where it will court not only clinical genetics labs, but specialists, academics, biotech, and pharma.
UK Genomic Analysis Firm Congenica Raises $10M
The company will use the proceeds from the round to invest in sales and marketing efforts for its Sapientia clinical genome analysis platform, as well as for R&D.